SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-146300
Filing Date
2016-09-23
Accepted
2016-09-23 16:26:49
Documents
7
Period of Report
2016-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-18897_18k.htm 8-K 32455
2 EX-1.1 a16-18897_1ex1d1.htm EX-1.1 181219
3 EX-5.1 a16-18897_1ex5d1.htm EX-5.1 14666
4 EX-99.1 a16-18897_1ex99d1.htm EX-99.1 10477
5 GRAPHIC g188971mmi001.gif GRAPHIC 4901
6 GRAPHIC g188971kii001.gif GRAPHIC 2785
7 GRAPHIC g188971kii002.jpg GRAPHIC 7272
  Complete submission text file 0001104659-16-146300.txt   261057
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 161900117
SIC: 2834 Pharmaceutical Preparations